Bookmark

Add to MyYahoo RSS

Vertex News

News on Vertex (Ticker: VRTX) continually updated from thousands of sources around the net.

Thursday Aug 14 | Business Journal

Six local companies with drugs in clinical trials for rare diseases

The longtime presence of companies like Genzyme, Shire and Vertex in the area has helped make Cambridge and the surrounding area a world center for rare disease drug research.

Comment?

Related Topix: Biotech, Medicine, Genzyme General, Healthcare Industry, Vertex Pharmaceuticals

Tue Aug 12, 2014

Business Journal

Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October

Vertex Pharmaceuticals has notified health care providers that it will stop selling its first blockbuster drug, Incivek, in about two months.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Thu Aug 07, 2014

Seeking Alpha

Vertex's Price And Prospects Compared To Alexion

In the past, I have written fairly negative assessments on the value of Vertex .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Vertex Pharmaceuticals, Gilead Sciences

Mon Aug 04, 2014

CRN

Net@Work Expands Sage Market Presence With Acquisition, Vertex Deal

Solution provider Net @ Work continues to expand its business within the Sage Software arena, recently acquiring another Sage reseller and striking a deal with Vertex to bring that developer's sales tax applications to the Sage market.

Comment?

Related Topix: Net at Work

Forbes.com

Nasdaq 100 Movers: CTRX, VRTX

In early trading on Monday, shares of Vertex Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.3%.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Financial Markets

Thu Jul 31, 2014

Business Wire

Vertex Receives European Approval for KALYDECOa (ivacaftor) in Eight Non-G551D Gating Mutations

Today's approval follows the positive opinion from the Committee for Medicinal Products for Human Use in June 2014.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

AmericanBankingNews.com

Vertex Pharmaceuticals's Neutral Rating Reaffirmed at Zacks

's stock had its "neutral" rating restated by Zacks in a report released on Thursday.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Tue Jul 29, 2014

Hispanic Business

Vertex Reports Second Quarter 2014 Financial Results and Provides...

Vertex reported total second quarter 2014 revenues of , which adds to the company's cash balance.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Healthcare Industry

Sun Jul 27, 2014

The Olympian

How will we pay for a $300,000 drug?

Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Cystic Fibrosis, Health, Fibrosis, Genetics, Healthcare Law, Law

Wed Jul 23, 2014

Chemical & Engineering News

Cystic Fibrosis Drug Combination May Be Counteracting Itself

Combination therapies are a promising strategy for correcting the most common gene mutation responsible for cystic fibrosis.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Fibrosis, Biotech, Vertex Pharmaceuticals, Healthcare Industry, University of North Carolina Chapel Hill

Boston.com

Tests suggest limitations to Vertex's cystic fibrosis treatment

Investors and patients were exuberant last month when Vertex Pharmaceuticals released results from clinical trials showing that cystic fibrosis patients' lung function improved on an experimental two-drug regimen.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Fibrosis, Biotech, Vertex Pharmaceuticals, Healthcare Industry, Healthcare Law, Food and Drug Administration, Law

Customer Interaction Solutions

Investor Alert: Class Action Lawsuit Against Vertex Pharmaceuticals...

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all purchasers of the common stock of Pharmaceuticals Incorporated between May 7, 2012 and May 29, 2012, inclusive .

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••